This product is a research grade chemical and not a pharmaceutical product. While the same active enantiomer (R-(−)-apomorphine) is an approved medicine, it is not manufactured, packaged, or regulated as a clinical dosage form, so it should not be used in humans.
A4393
R-(−)-Apomorphine hydrochloride hemihydrate
calcined, ≥98% (with NaOH, titration)
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|
About This Item
Linear Formula:
C17H17NO2 · HCl · 1/2H2O
CAS Number:
Molecular Weight:
312.79
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352210
EC Number:
206-243-0
MDL number:
Assay:
≥98% (with NaOH, titration)
Form:
calcined, (Powder to Crystalline Powder)
Quality level:
Storage condition:
protect from light, under inert gas
Pricing and availability is not currently available.
Quality Level
assay
≥98% (with NaOH, titration)
form
calcined, (Powder to Crystalline Powder)
storage condition
protect from light, under inert gas
color
white to gray
mp
285-287 °C (lit.)
solubility
H2O: ~10 mg/mL, clear, yellow-green
SMILES string
Cl[H].Cl[H].[H]O[H].[H][C@]12Cc3ccc(O)c(O)c3-c4cccc(CCN1C)c24.[H][C@]56Cc7ccc(O)c(O)c7-c8cccc(CCN5C)c68
InChI
1S/2C17H17NO2.2ClH.H2O/c2*1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2*2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t2*13-;;;/m11.../s1
InChI key
CXWQXGNFZLHLHQ-DPFCLETOSA-N
Gene Information
human ... DRD1(1812), DRD2(1813), DRD3(1814), DRD4(1815), DRD5(1816)
Application
R-(-)-Apomorphine hydrochloride hemihydrate has been used as a dopamine receptor agonist to study its effects of rotational behavior in rat models of Parkinson′s disease.[1]
Biochem/physiol Actions
R-(−)-Apomorphine acts as a non-selective D1 and D2 dopamine receptor agonist. It shows therapeutic effects against Parkinson′s disease and male erectile dysfunction. R-(−)-Apomorphine also shows neuroprotective, radical scavenging, and emetic effects. Apomorphine stimulates the brain chemoreceptor trigger zone. It stimulates the chemoreceptor trigger zone in the brain.
1 of 1
This Item | |||
|---|---|---|---|
| form calcined, (Powder to Crystalline Powder) | form solid | form solid | form solid |
| assay ≥98% (with NaOH, titration) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay - |
| Quality Level 200 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| storage condition protect from light, under inert gas | storage condition desiccated, under inert gas | storage condition desiccated, under inert gas | storage condition under inert gas |
| solubility H2O: ~10 mg/mL, clear, yellow-green | solubility DMSO: ~14 mg/mL, H2O: >5 mg/mL | solubility DMSO: >20 mg/mL, H2O: ≥5 mg/mL | solubility H2O: 22 mg/mL at ~60 °C |
| color white to gray | color - | color white | color white |
signalword
Danger
hcodes
pcodes
Hazard Classifications
Acute Tox. 3 Oral
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Y H Dang et al.
Neuroscience, 169(4), 1872-1880 (2010-07-06)
The present study examined the role of dopamine and D(1)-and D(2)-like dopamine receptors in ventrolateral orbital cortex (VLO)-evoked anti-hypersensitivity in a rat model of neuropathic pain, as well as the possible underlying mechanisms. Results showed that microinjection of apomorphine [(R(-)-apomorphine
Kristina Malinovskaja et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 83(3), 477-484 (2012-12-05)
The objective of this study was to test a drug delivery system that combines iontophoresis and cation-exchange fibers as drug matrices for the controlled transdermal delivery of antiparkinsonian drug apomorphine. Positively charged apomorphine was bound to the ion-exchange groups of
Fumitoshi Kodaka et al.
European journal of nuclear medicine and molecular imaging, 40(4), 574-579 (2012-12-15)
Dopamine D receptors (DRs) have two affinity states for endogenous dopamine, referred to as high-affinity state (D ), which has a high affinity for endogenous dopamine, and low-affinity state (D ). The density of D can be measured with (R)-2-CHO-N-n-propylnorapomorphine
Global Trade Item Number
| SKU | GTIN |
|---|---|
| A4393-5G | 04061832088648 |
| A4393-100MG | 04061833374399 |
| A4393-250MG | 04061833374412 |
| A4393-1G | 04061833374405 |